Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ELV
|
Gail Boudreaux
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 15,352 Reduced 15.18% |
$6,931,428
$451.5 p/Share
|
Mar 01
2022 |
ELV
|
Felicia F Norwood
EVP & President,Gov Health Ben |
BUY
Grant, award, or other acquisition
|
Direct | 9,196 Added 24.15% |
-
|
Mar 01
2022 |
ELV
|
Felicia F Norwood
EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct | 3,568 Reduced 15.34% |
$1,610,952
$451.5 p/Share
|
Mar 01
2022 |
ELV
|
Blair Williams Todt
EVP, CLO & CAO |
BUY
Grant, award, or other acquisition
|
Direct | 1,883 Added 29.89% |
-
|
Mar 01
2022 |
ELV
|
Blair Williams Todt
EVP, CLO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 191 Reduced 7.01% |
$86,236
$451.5 p/Share
|
Mar 01
2022 |
ELV
|
Peter D Haytaian
EVP & Pres Carelon & CarelonRx |
BUY
Grant, award, or other acquisition
|
Direct | 10,465 Added 26.85% |
-
|
Mar 01
2022 |
ELV
|
Peter D Haytaian
EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct | 4,667 Reduced 20.55% |
$2,107,150
$451.5 p/Share
|
Mar 01
2022 |
ELV
|
Charles Morgan Kendrick Jr
EVP & President, Commercial |
BUY
Grant, award, or other acquisition
|
Direct | 3,969 Added 21.33% |
-
|
Mar 01
2022 |
ELV
|
Charles Morgan Kendrick Jr
EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct | 804 Reduced 7.01% |
$363,006
$451.5 p/Share
|
Mar 01
2022 |
ELV
|
Gloria M Mccarthy
EVP & Chief Administrative Off |
BUY
Grant, award, or other acquisition
|
Direct | 10,465 Added 14.6% |
-
|
Mar 01
2022 |
ELV
|
Gloria M Mccarthy
EVP & Chief Administrative Off |
SELL
Payment of exercise price or tax liability
|
Direct | 4,871 Reduced 8.76% |
$2,199,256
$451.5 p/Share
|
Mar 01
2022 |
ELV
|
John E Gallina
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 11,157 Added 16.13% |
-
|
Mar 01
2022 |
ELV
|
John E Gallina
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,162 Reduced 8.16% |
$1,879,143
$451.5 p/Share
|
Mar 01
2022 |
ELV
|
Ronald W Penczek
CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct | 1,175 Added 29.43% |
-
|
Mar 01
2022 |
ELV
|
Ronald W Penczek
CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 369 Reduced 18.34% |
$166,604
$451.5 p/Share
|
Mar 01
2022 |
ENOV
|
Patricia A Lang
SVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct | 379 Reduced 1.09% |
$14,978
$39.52 p/Share
|
Mar 01
2022 |
ENOV
|
Christopher M Hix
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,800 Reduced 1.24% |
$71,118
$39.51 p/Share
|
Mar 01
2022 |
EGIO
|
Michael Di Santo
Chief Admin. & Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,429 Reduced 0.43% |
$13,167
$3.84 p/Share
|
Mar 01
2022 |
EGIO
|
Daniel R Boncel
Former PAO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,947 Reduced 0.81% |
$11,316
$3.84 p/Share
|
Mar 01
2022 |
EGIO
|
Bob Lyons
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 30,004 Reduced 2.83% |
$115,215
$3.84 p/Share
|
Mar 01
2022 |
EGIO
|
Christine Cross
Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,851 Reduced 0.62% |
$7,108
$3.84 p/Share
|
Mar 01
2022 |
PSTV
|
Andrew John Hugh Mac Intyre Sims
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 2,000 Added 17.81% |
$2,200
$1.1 p/Share
|
Mar 01
2022 |
PHIO
|
Gerrit Dispersyn
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 8,954 Reduced 4.05% |
$7,342
$0.82 p/Share
|
Mar 01
2022 |
PHIO
|
Caitlin Kontulis
Secretary & VP Finance & Admin |
SELL
Payment of exercise price or tax liability
|
Direct | 4,011 Reduced 3.72% |
$3,289
$0.82 p/Share
|
Mar 01
2022 |
YTEN
|
Kristi Snell
VP Research and CSO |
SELL
Payment of exercise price or tax liability
|
Direct | 418 Reduced 3.6% |
$1,776
$4.25 p/Share
|
Mar 01
2022 |
YTEN
|
Lynne H Brum
VP Planning and Communications |
SELL
Payment of exercise price or tax liability
|
Direct | 366 Reduced 3.46% |
$1,556
$4.25 p/Share
|
Mar 01
2022 |
YTEN
|
Oliver P Peoples
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,827 Reduced 3.53% |
$7,765
$4.25 p/Share
|
Mar 01
2022 |
YTEN
|
Charles B Haaser
VP Finance and CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 341 Reduced 2.74% |
$1,449
$4.25 p/Share
|
Mar 01
2022 |
CRTD
|
Chelsea Pullano
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 1,429 Added 13.39% |
$2,501
$1.75 p/Share
|
Mar 01
2022 |
CRTD
|
Jeremy Frommer
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 180,000 Added 24.21% |
$315,000
$1.75 p/Share
|
Mar 01
2022 |
CRTD
|
Justin Fontaine Maury
COO & President |
BUY
Open market or private purchase
|
Direct | 5,714 Added 5.04% |
$10,000
$1.75 p/Share
|
Mar 01
2022 |
CRTD
|
Laurie Weisberg
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 28,571 Added 32.8% |
$49,999
$1.75 p/Share
|
Mar 01
2022 |
IMH
|
George A. Mangiaracina
CHAIRMAN, CHIEF EXEC. & DIR. |
SELL
Open market or private sale
|
Direct | 6,200 Reduced 2.49% |
$4,464
$0.72 p/Share
|
Mar 01
2022 |
GIPRW
|
Benjamin Adams |
BUY
Grant, award, or other acquisition
|
Direct | 7,143 Added 36.99% |
-
|
Mar 01
2022 |
GIPRW
|
Patrick Quilty |
BUY
Grant, award, or other acquisition
|
Direct | 7,143 Added 33.56% |
-
|
Mar 01
2022 |
GIPRW
|
Betsy Peck |
BUY
Grant, award, or other acquisition
|
Direct | 7,143 Added 24.39% |
-
|
Mar 01
2022 |
GIPRW
|
Stuart Eisenberg |
BUY
Grant, award, or other acquisition
|
Direct | 7,143 Added 32.05% |
-
|
Mar 01
2022 |
GIPRW
|
Gena Cheng |
BUY
Grant, award, or other acquisition
|
Direct | 7,143 Added 50.0% |
-
|
Mar 01
2022 |
SCKT
|
Leonard L Ott
Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 967 Reduced 1.48% |
$3,800
$3.93 p/Share
|
Mar 01
2022 |
SCKT
|
Lynn Zhao
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 967 Reduced 1.35% |
$3,800
$3.93 p/Share
|
Mar 01
2022 |
PBBK
|
Janak M Amin
President and CEO |
BUY
Open market or private purchase
|
Indirect | 2,500 Added 5.03% |
$34,625
$13.85 p/Share
|
Mar 01
2022 |
HZN
|
Jay Goldbaum
General Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 26,994 Added 11.56% |
-
|
Mar 01
2022 |
HZN
|
Jay Goldbaum
General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 2,880 Reduced 1.58% |
$15,149
$5.26 p/Share
|
Mar 01
2022 |
HZN
|
Dennis E. Richardville
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 20,422 Added 23.7% |
-
|
Mar 01
2022 |
HZN
|
Dennis E. Richardville
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,197 Reduced 2.57% |
$6,236
$5.21 p/Share
|
Mar 01
2022 |
HZN
|
Matthew Pollick
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 24,340 Added 25.65% |
-
|
Mar 01
2022 |
HZN
|
Matthew Pollick
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,333 Reduced 2.8% |
$6,945
$5.21 p/Share
|
Mar 01
2022 |
HZN
|
Terry Gohl
President, CEO |
BUY
Grant, award, or other acquisition
|
Direct | 123,608 Added 28.64% |
-
|
Mar 01
2022 |
HZN
|
Terry Gohl
President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,625 Reduced 2.45% |
$24,096
$5.21 p/Share
|
Mar 01
2022 |
HZN
|
Matthew Joseph Meyer |
BUY
Grant, award, or other acquisition
|
Direct | 10,948 Added 16.36% |
-
|
Mar 01
2022 |